Taking an aspirin a day has many health benefits, and reducing prostate cancer may be one of them. New research shows men who use aspirin or other blood thinners after treatment for prostate cancer have a substantially lower risk of dying or seeing the cancer spread to another organ.
Christopher Logothetis, M.D., a medical oncologist at the University of Texas MD Anderson Cancer Center in Houston, said the study is in line with others that suggest aspirin's blood-thinning and anti-inflammatory properties reduce the risk of many kinds of cancer.
"Anti-inflammatory" is the key word here. The Prostate Storm discusses at some length the connection between inflammation in the prostate with the occurrence of cancer. The notion is that if you can reduce prostatic inflammation (prostatitis, by definition) through an anti-inflammatory diet, you can reduce prostate cancer as well.
Christopher Logothetis, M.D., a medical oncologist at the University of Texas MD Anderson Cancer Center in Houston, said the study is in line with others that suggest aspirin's blood-thinning and anti-inflammatory properties reduce the risk of many kinds of cancer.
"Anti-inflammatory" is the key word here. The Prostate Storm discusses at some length the connection between inflammation in the prostate with the occurrence of cancer. The notion is that if you can reduce prostatic inflammation (prostatitis, by definition) through an anti-inflammatory diet, you can reduce prostate cancer as well.
Despite growing evidence, it remains a somewhat controversial idea. But the prostate cancer-inflammation connection is gaining more momentum as researchers call for more studies like this aspirin-cancer study.
This study followed nearly 5300 men with prostate cancer. In those taking blood-thinners such as aspirin, only 4% died from reoccurrence of cancer, compared to 10% who did not take any medication.
No comments:
Post a Comment